About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Online First
Pancytopenia Complicating Varicella
Rajeshwari K, Somakumar V, Sachan S, Chetty Y, Kumar D, Anuradha S
Case Report JCR (Online February 25, 2025)
DOI : http://dx.doi.org/10.17659/01.2025.0005
FULL TEXT | ABSTRACT | PDF
Rapid Clinical Recovery After Discontinuing Aspartame-Containing Chewing Gum
Jonathan E. Prousky
Case Report JCR (Online February 15, 2025)
DOI : http://dx.doi.org/10.17659/01.2025.0004
FULL TEXT | ABSTRACT | PDF
Robotic Technology Enabled Gait Training Methods: A Boon for Gait Rehabilitation in Incomplete Tetraplegia
Thangavelu Senthilvelkumar, Joy Christy, Radhakrishnan Yuvaraj, Prashanth H Chalageri, Raji Thomas
Case Report JCR (Online January 25, 2025)
DOI : http://dx.doi.org/10.17659/01.2025.0003
FULL TEXT | ABSTRACT | PDF
Subcutaneous Mercury Injection for Self-Harm: Early Intervention and Successful Outcome
Muzamil Noor Malik, Kanattage Kelum Perera, Ambreen Qadir
Case Report JCR (Online January 15, 2025)
DOI : http://dx.doi.org/10.17659/01.2025.0002
FULL TEXT | ABSTRACT | PDF
Mucormycosis Involving Maxillary Sinus
SR Swarna, Karaunakaran Vignesh, S Vijayashankar, Bharathi, Jeyakumari
Case Report JCR (Online January 05, 2025)
DOI : http://dx.doi.org/10.17659/01.2025.0001
FULL TEXT | ABSTRACT | PDF

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Mar 17, 2025